| 1. |
News in brief... |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1241,
2000,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
| 2. |
Choice of primary outcome alters success of stroke trials? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1241,
2000,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
| 3. |
Addressing antineoplastic drug waste |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1241,
2000,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
| 4. |
The rocky road to the NICE approval of taxanes |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1241,
2000,
Page 5-6
Mark Greener,
Preview
|
|
摘要:
For the last few years, the taxanes*formed the focus of intense media scrutiny in the UK. They were the epitome of so-called 'postcode prescribing': people in one health authority received a drug denied to others because the authorities took different views about the evidence base. Prime Minister Tony Blair pledged to end postcode prescribing, largely by using the National Institute for Clinical Excellence (NICE).
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
| 5. |
MDI/spacer favoured over nebuliser for young children with acute asthma |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1241,
2000,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
| 6. |
Mycobacterium vaccaevaccine improves severity of TB |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1241,
2000,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
| 7. |
Insulin glargine: potential benefits over insulin suspension isophane |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1241,
2000,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
| 8. |
Once-daily 'Concerta' attention-grabbing in ADHD |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1241,
2000,
Page 9-9
Carmen Innes,
Preview
|
|
摘要:
A long term study has shown that a new once-daily formulation of methylphenidate is effective and well tolerated in children with attention deficit hyperactivity disorder (ADHD) over the course of 1 year. The study, presented at the 153rd Annual Meeting of the American Psychiatric Association [Chicago, US; May 2000] is one of the largest studies to be carried out evaluating long term use of this extended-release formulation of methylphenidate, called 'OROS' methylphenidate ['Concerta'].
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
| 9. |
News in brief... |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1241,
2000,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
| 10. |
News in brief... |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1241,
2000,
Page 11-11
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
首页
